HbA1c reflects mean BG over the prior three to four months and is currently the only long-term glycemic control measure with robust outcome data. Multiple studies in diverse populations have… Click to show full abstract
HbA1c reflects mean BG over the prior three to four months and is currently the only long-term glycemic control measure with robust outcome data. Multiple studies in diverse populations have shown that elevated HbA1c values are associated with chronic complications of diabetes. Intensive management resulting in lower HbA1c concentrations is associated with fewer and delayed development of microvascular and macrovascular chronic complications 1-5 , see Chapter 18 (ref). Additionally, lower HbA1c shortly after diagnosis is associated with a lower risk of subsequent complications 6,7 . This article is protected by copyright. All rights reserved.
               
Click one of the above tabs to view related content.